Soha Yazbek1, Khalil Kreidieh1, Sami Ramia2. 1. Department of Medical Laboratory Sciences, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon. 2. Department of Medical Laboratory Sciences, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon. sramia@aub.edu.lb.
Abstract
PURPOSE: Hepatitis E virus (HEV) is mainly transmitted through contaminated water supplies which make the virus endemic in developing countries including countries of the Middle East and North Africa (MENA) region. Recent reports suggest potential risk of HEV transmission via blood transfusion. METHODS: Related articles on HEV were collected by searching through the 25 countries of the MENA region using Pubmed and Medline within the past 14 years: January 2000-August 2014. RESULTS: One hundred articles were extracted, of which 25 were not eligible. The articles discussed the seroprevalence of HEV and HEV markers in 12 countries. Eight articles provided data on HEV in blood donors. The seroprevalence of HEV in the general MENA population ranged from 2.0 to 37.5% and was higher in males than in females. Prevalence increased with age, but exposure seems to be in early life. CONCLUSIONS: In the MENA region, the role of HEV as an infectious threat to blood safety is under-investigated. More data are needed to quantify the risk of transmission and to assess clinical outcomes. This requires, at least, surveillance screening of donors and recipients for HEV markers using sensitive and specific serological tests. At the present time, serious consideration should be given to selective screening for certain groups of patients (e.g., immunocompromised, pregnant women and others) who commonly require blood transfusion and are at high risk of hepatic failure or chronicity from HEV infection.
PURPOSE:Hepatitis E virus (HEV) is mainly transmitted through contaminated water supplies which make the virus endemic in developing countries including countries of the Middle East and North Africa (MENA) region. Recent reports suggest potential risk of HEV transmission via blood transfusion. METHODS: Related articles on HEV were collected by searching through the 25 countries of the MENA region using Pubmed and Medline within the past 14 years: January 2000-August 2014. RESULTS: One hundred articles were extracted, of which 25 were not eligible. The articles discussed the seroprevalence of HEV and HEV markers in 12 countries. Eight articles provided data on HEV in blood donors. The seroprevalence of HEV in the general MENA population ranged from 2.0 to 37.5% and was higher in males than in females. Prevalence increased with age, but exposure seems to be in early life. CONCLUSIONS: In the MENA region, the role of HEV as an infectious threat to blood safety is under-investigated. More data are needed to quantify the risk of transmission and to assess clinical outcomes. This requires, at least, surveillance screening of donors and recipients for HEV markers using sensitive and specific serological tests. At the present time, serious consideration should be given to selective screening for certain groups of patients (e.g., immunocompromised, pregnant women and others) who commonly require blood transfusion and are at high risk of hepatic failure or chronicity from HEV infection.
Entities:
Keywords:
Blood donors; Blood safety; Epidemiology; HEV; Hepatitis E; MENA region
Authors: M A Darwish; R Faris; N Darwish; A Shouman; M Gadallah; M S El-Sharkawy; R Edelman; K Grumbach; M R Rao; J D Clemens Journal: Am J Trop Med Hyg Date: 2001 Mar-Apr Impact factor: 2.345
Authors: Jason T Blackard; Susan D Rouster; Soad Nady; Gehan Galal; Naglaa Marzuuk; Marwaa M Rafaat; Enas Daef; Salwa Seif El Din; Robert H Purcell; Suzanne U Emerson; Kenneth E Sherman; M Tarek Shata Journal: J Clin Virol Date: 2009-08-03 Impact factor: 3.168
Authors: Patricia Momoyo Yoshimura Zitelli; Michele Gomes-Gouvêa; Daniel F Mazo; Julio da Motta Singer; Claudia P M S Oliveira; Alberto Queiroz Farias; João Renato Pinho; Ryan Yukimatsu Tanigawa; Venâncio Avancini Ferreira Alves; Flair José Carrilho; Mário Guimarães Pessoa Journal: Clinics (Sao Paulo) Date: 2021-11-26 Impact factor: 2.365
Authors: Pengfei Li; Jiaye Liu; Yang Li; Junhong Su; Zhongren Ma; Wichor M Bramer; Wanlu Cao; Robert A de Man; Maikel P Peppelenbosch; Qiuwei Pan Journal: Liver Int Date: 2020-04-24 Impact factor: 5.828
Authors: Enas S Al Absi; Duaa W Al-Sadeq; Makiyeh Khalili; Nadin Younes; Nader Al-Dewik; Sara K Abdelghany; Somaia S Abouzid; Asma A Al Thani; Hadi M Yassine; Peter V Coyle; Gheyath K Nasrallah Journal: BMC Gastroenterol Date: 2021-06-15 Impact factor: 3.067
Authors: Janine Zöllkau; Juliane Ankert; Mathias W Pletz; Sasmita Mishra; Gregor Seliger; Silvia M Lobmaier; Clarissa U Prazeres Da Costa; Vera Seidel; Katharina von Weizsäcker; Alexandra Jablonka; Christian Dopfer; Michael Baier; Thomas Horvatits; Ingrid Reiter-Owona; Tanja Groten; Benjamin T Schleenvoigt Journal: Pathogens Date: 2022-01-03